|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 8/01/23 Exelixis, Inc. 10-Q 6/30/23 71:6.8M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 805K
2: EX-10.1 Material Contract HTML 134K
3: EX-31.1 Certification -- §302 - SOA'02 HTML 26K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 26K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 24K
11: R1 Cover Page HTML 74K
12: R2 Condensed Consolidated Balance Sheets HTML 130K
13: R3 Condensed Consolidated Balance Sheets HTML 40K
(Parenthetical)
14: R4 Condensed Consolidated Statements of Income HTML 92K
15: R5 Condensed Consolidated Statements of Comprehensive HTML 43K
Income
16: R6 Condensed Consolidated Statements of Comprehensive HTML 24K
Income (Parenthetical)
17: R7 Condensed Consolidated Statements of Stockholders' HTML 84K
Equity
18: R8 Condensed Consolidated Statements of Cash Flows HTML 97K
19: R9 Organization and Summary of Significant Accounting HTML 37K
Policies
20: R10 Revenues HTML 124K
21: R11 Collaboration Agreements And Business Development HTML 56K
Activities
22: R12 Cash and Investments HTML 92K
23: R13 Fair Value Measurements HTML 59K
24: R14 Inventory HTML 34K
25: R15 Stockholders? Equity HTML 61K
26: R16 Provision For Income Taxes HTML 26K
27: R17 Net Income Per Share HTML 49K
28: R18 Commitments and Contingencies HTML 41K
29: R19 Pay vs Performance Disclosure HTML 34K
30: R20 Insider Trading Arrangements HTML 41K
31: R21 Organization and Summary of Significant Accounting HTML 55K
Policies (Policies)
32: R22 Revenues (Tables) HTML 124K
33: R23 Collaboration Agreements And Business Development HTML 45K
Activities (Tables)
34: R24 Cash and Investments (Tables) HTML 93K
35: R25 Fair Value Measurements (Tables) HTML 54K
36: R26 Inventory (Tables) HTML 35K
37: R27 Stockholders? Equity (Tables) HTML 54K
38: R28 Net Income Per Share (Tables) HTML 50K
39: R29 Organization and Summary of Significant Accounting HTML 29K
Policies (Details)
40: R30 Revenues - Revenues by Disaggregated Category HTML 43K
(Details)
41: R31 Revenues - Revenues Disaggregated by Concentration HTML 48K
Risks (Details)
42: R32 Revenues - Revenues Disaggregated by Geographic HTML 36K
Region (Details)
43: R33 Revenues - Net Product Revenues Disaggregated by HTML 36K
Product (Details)
44: R34 Revenues - Activities and Ending Reserve Balances HTML 43K
for Significant Categories of Discounts and
Allowances (Details)
45: R35 Revenues - Contract Assets and Liabilities HTML 41K
(Details)
46: R36 Collaboration Agreements And Business Development HTML 37K
Activities - Collaboration Revenues under the
Collaboration Agreement with Ipsen (Details)
47: R37 Collaboration Agreements And Business Development HTML 26K
Activities - Ipsen Collaboration Narrative
(Details)
48: R38 Collaboration Agreements And Business Development HTML 37K
Activities - Collaboration Revenues under the
Collaboration Agreement with Takeda (Details)
49: R39 Collaboration Agreements And Business Development HTML 34K
Activities - Takeda Collaboration Narrative
(Details)
50: R40 Collaboration Agreements And Business Development HTML 30K
Activities -Royalty Pharma Narrative (Details)
51: R41 Collaboration Agreements And Business Development HTML 34K
Activities - Research Collaborations and
In-Licensing Arrangements Narrative (Details)
52: R42 Cash and Investments - Investments by Security HTML 71K
Type (Details)
53: R43 Cash and Investments - Narrative (Details) HTML 49K
54: R44 Cash and Investments - Fair Value and Gross HTML 35K
Unrealized Losses of Investments
Available-for-Sale in an Unrealized Loss Position
(Details)
55: R45 Cash and Investments - Fair Value of Cash HTML 30K
Equivalents and Investments by Contractual
Maturity (Details)
56: R46 Fair Value Measurements (Fair Value Hierarchy) HTML 69K
(Details)
57: R47 Fair Value Measurements - Narratives (Details) HTML 31K
58: R48 Inventory (Details) HTML 34K
59: R49 Stockholders' Equity - Narrative (Details) HTML 98K
60: R50 Stockholders? Equity - Schedule of Allocated HTML 30K
Employee Stock-Based Compensation Expense
(Details)
61: R51 Stockholders? Equity - Schedule of Employee HTML 42K
Service Share - Based Compensation Expense
(Details)
62: R52 Stockholders? Equity - Estimate Grant-Date Fair HTML 41K
Value (Details)
63: R53 Provision For Income Taxes (Details) HTML 23K
64: R54 Net Income Per Share - Computation of Basic and HTML 56K
Diluted Net Income Per Share (Details)
65: R55 Net Income Per Share - Potential Shares of Common HTML 26K
Stock Not Included in the Computation of Diluted
Net Income Per Share (Details)
66: R56 Commitments and Contingencies (Details) HTML 29K
69: XML IDEA XML File -- Filing Summary XML 129K
67: XML XBRL Instance -- exel-20230630_htm XML 1.54M
68: EXCEL IDEA Workbook of Financial Report Info XLSX 88K
7: EX-101.CAL XBRL Calculations -- exel-20230630_cal XML 156K
8: EX-101.DEF XBRL Definitions -- exel-20230630_def XML 472K
9: EX-101.LAB XBRL Labels -- exel-20230630_lab XML 1.42M
10: EX-101.PRE XBRL Presentations -- exel-20230630_pre XML 845K
6: EX-101.SCH XBRL Schema -- exel-20230630 XSD 135K
70: JSON XBRL Instance as JSON Data -- MetaLinks 415± 570K
71: ZIP XBRL Zipped Folder -- 0000939767-23-000079-xbrl Zip 283K
 | Download this zipped .zip folder |
| Files: | exel-20230630.htm exel-20230630.xsd exel-20230630_cal.xml exel-20230630_def.xml exel-20230630_g1.jpg exel-20230630_lab.xml exel-20230630_pre.xml exel20230630exhibit10110q.htm exel20230630exhibit31110q.htm exel20230630exhibit31210q.htm exel20230630exhibit32110q.htm |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/05/21 Exelixis, Inc. 10-Q 7/02/21 71:7.7M 3/03/21 Exelixis, Inc. 8-K:3,5,9 2/25/21 13:651K |